→
Previous
Latest
House File 310 - Introduced HOUSE FILE 310 BY COMMITTEE ON STATE GOVERNMENT (SUCCESSOR TO HSB 64) A BILL FOR An Act relating to the practice of optometry.
House File 310 - Enrolled House File 310 AN ACT RELATING TO THE PRACTICE OF OPTOMETRY.
TLSB 1540HV (2) 88 ss/rn H.F.
Section 1.
310 Section 1.
Section 154.1, subsection 3, Code 2020, is amended to read as follows:
Section 154.1, subsection 3, Code 2019, is amended to read as follows:
A Notwithstanding paragraph “b”, a license to practice optometry under this chapter does not authorize the performance of surgical procedures which require the use of injectable or general anesthesia, moderate sedation, penetration of the globe, or the use of ophthalmic lasers for the purpose of ophthalmic surgery within or upon the globe.
A license to practice optometry under this chapter does not authorize the performance of surgical procedures which require the use of injectable or general anesthesia, moderate sedation, penetration of the globe, or the use of ophthalmic lasers for the purpose of ophthalmic surgery within or upon the globe.
(a) Sub-conjunctival injections for the medical treatment of the eye.
House File 310, p.
2 (a) Sub-conjunctival injections for the medical treatment of the eye.
(c) Local anesthetic for the purpose of draining an eyelid abscess.
(c) Botulinum toxin to the muscles of facial expression innervated by the facial nerve, including for cosmetic purposes.
(2) An optometrist shall not administer any injection prior to receiving approval from the board.
(2) A licensed optometrist shall not administer any injection prior to receiving approval from the board.
(3) The board shall not approve the use of injections other than to counteract an anaphylactic reaction unless the optometrist demonstrates to the board sufficient educational or clinical training from a college or university accredited LSB 1540HV (2) 88 -1- ss/rn 1/3 H.F.
(3) The board shall not approve the use of injections other than to counteract an anaphylactic reaction unless the licensed optometrist demonstrates to the board sufficient educational or clinical training from a college or university accredited by a regional or professional accreditation organization which is recognized or approved by the council for higher education accreditation or by the United States department of education, or clinical training equivalent to clinical training offered by such an institution.
310 by a regional or professional accreditation organization which is recognized or approved by the council for higher education accreditation or by the United States department of education or clinical training equivalent to clinical training offered by such an institution.
Training for the administration and side effects of injection treatment for chalazia and of botulinum toxin shall be required before a licensed optometrist may administer such injections.
A license granted to an applicant who graduated from an accredited school of optometry and who passed the injections skills examination of the national board of examiners in optometry examination on or after January 1, 2011 shall constitute proof of sufficient educational or clinical training.
The board shall adopt rules regarding training required pursuant to this subparagraph and approve training providers.
b.
A licensed optometrist may employ and, notwithstanding section 147.107, supply pharmaceutical- delivering contact lenses for the purpose of treatment of conditions of the human eye and adnexa.
A licensed optometrist may employ and, notwithstanding section 147.107, supply pharmaceutical-delivering contact lenses for the purpose of treatment of conditions of the human eye and adnexa.
A licensed optometrist may be authorized, where reasonable and appropriate, by rule of the board, to employ new diagnostic and therapeutic pharmaceutical agents approved by the United States food and drug administration on or after July 1, 2002, for the diagnosis and treatment of the human eye and adnexa.
A licensed optometrist may be authorized, where reasonable and appropriate, by rule of the board, to employ new diagnostic and therapeutic pharmaceutical agents approved by House File 310, p.
3 the United States food and drug administration on or after July 1, 2002, for the diagnosis and treatment of the human eye and adnexa.
The therapeutic efforts of a licensed optometrist are intended for the purpose of examination, diagnosis, and LSB 1540HV (2) 88 -2- ss/rn 2/3 H.F.
The therapeutic efforts of a licensed optometrist are intended for the purpose of examination, diagnosis, and treatment of visual defects, abnormal conditions, and diseases of the human eye and adnexa, for proper optometric practice or referral for consultation or treatment to persons licensed under chapter 148.
310 treatment of visual defects, abnormal conditions, and diseases of the human eye and adnexa, for proper optometric practice or referral for consultation or treatment to persons licensed under chapter 148.
EXPLANATION The inclusion of this explanation does not constitute agreement with the explanation’s substance by the members of the general assembly.
______________________________ ______________________________ PAT GRASSLEY CHARLES SCHNEIDER Speaker of the House President of the Senate I hereby certify that this bill originated in the House andis known as House File 310, Eighty-eighth General Assembly.
This bill relates to the practice of optometry.
______________________________ MEGHAN NELSON Chief Clerk of the House Approved _______________, 2020 ______________________________ KIM REYNOLDS Governor
The bill allows optometrists to administer sub-conjunctival injections for the medical treatment of the eye, intra-lesional injections for the treatment of chalazia, local anesthetic for the purpose of draining an eyelid abscess, and injections to counteract an anaphylactic reaction.
Current law prohibits an optometrist from administering injections other than to counter an anaphylactic reaction.
The bill prohibits an optometrist from administering any injection prior to receiving approval from the board.
The board shall not approve the use of injections by an optometrist, except for injections to counteract an anaphylactic reaction, unless the optometrist demonstrates sufficient educational or clinical training from or equivalent to an accredited college or university.
The bill directs the board to accept a license to practice optometry issued to an applicant who graduated from an accredited school of optometry and who passed the injections skills portion of the national board of examiners in optometry examination on or after January 1, 2011, as proof of sufficient educational or clinical training.
LSB 1540HV (2) 88 -3- ss/rn 3/3
⬇ Download PDF